List of Laws, EOs, AOs, MCs, And BCs

5921 8981 3720 9711 8172 9211 6425 9165 8203 6675 7394 7581 7432 9257 9994 7876 8423 9502

Pharmacy Law (as amended by EO 174) PRC Modernization Act of 2000 Foods, Drugs, Cosmetics, and Devices Act (as amended by EO 175 s 1987) Food and Drug Administration Act of 2009 An Act for Salt Ionization Nationwide (ASIN) Tobacco Regulation Act of 2003 Dangerous Drug Act of 1972 Comprehensive Dangerous Drug Act of 2002 Special Law on Counterfeit Drugs Generic Act of 1988 Consumer Act of the Philippines The Price Act Senior Citizens Act Expanded Senior Citizens Act of 2003 Expanded Senior Citizens Act of 2010 Senior Citizens Center Act of the Philippines Traditional and Alternative Medicines Act of 1997 Universally Accessible Cheaper and Quality Medicines Act of 2008

EO 119 EO 851

June 23, 1979 December 5, 2000 June 22, 1963 August 18, 2009 December 29, 1995 June 23, 2003 March 30, 1972 June 7, 2002 September 4, 1996 September 13, 1988 April 13, 1992 May 27, 1992 February 7, 1992 February 26, 2004 February 15, 2010 February 14, 1995 December 9, 1997 June 6, 2008

Reorganizing the BFAD/DOH; BFAD as monitoring arm Created BFAD and abolished FDA (December 2, 1982)

Administrative Orders: AO 220 s 1974 AO 42 s 1982 AO 79 s 1989 AO 85 s 1990 AO 99 s1990 AO 311 s 1977 AO 55 s 1988 AO 64 s 1988 AO 56 s 1986 AO 67 s 1989 AO 103 s 2002 AO 4 s 1992 AO 27 s 2001 AO 47-A s 1999 AO 29-A s 1994

cGMP Drug Registration of Herbal and Traditional Drugs Transitional Remedial Labeling Req’ts for labeling certain categories of drugs with 2 or more active Labeling with 4 or more active Labeling hazardous Labeling materials of pharmaceutical products Amendment to AO 55 Revised licensing of drug outlets Revised rules and regulations of registration of pharmaceutical products Batch certificates of antibiotics Compassionate special permit Local manufacturers of vaccines and biological products Clinical Trials Part D-5 cosmetics; listing of cosmetics specialty

Memorandum Circular No. 17 s 1989 15 s 1990 5 s 1991 9 s 1990 1 s 1991 19 s 1992 5 s 1994

Monitoring of drugstore; RPh office hours Exemption from requirement providing 1 RPh for each activity Designation of official liaison officer Revised implementation guidelines for AO 151 Registration of medical devices and diagnostic reagents Specific standards and requirements for cosmetics Reports of ADRs

Bureau Circular No. 2 s 1997 21 s 1999 4 s 1999 6 s 1999

Accreditation of drug liaison officer to BFAD Evaluation of brand names New protocol for registration of drug, food, cosmetics, and medical devices Revised BC 4 s 1999

Ramos Arroyo Ramos